LAS VEGAS, April 27, 2018 -- VITALIBIS, INC. (OTCQB:VCBD) a technology-based seller of premium, full spectrum phyto-cannabinoid rich (PCR) hemp oil products, along with personal care and certified organic nutritional products formulated with premium hemp extracts, announced today that its stock has commenced trading on the OTCQB Market (“OTCQB”) after successfully uplisting from the OTC Pink Market.
While OTCQB membership requires more comprehensive compliance requirements from its members, it correspondingly provides significantly enhanced investor benefits, including higher reporting standards, increased analyst coverage and access to news services.
Steven Raack, CEO of Vitalibis said, "As we build the Vitalibis brand, our goal is to consistently improve – with our product formulations, with our technology innovation and with our social impact. Upticking to OTCQB is another positive improvement. Trading on the OTCQB will provide our shareholders and prospective investors a greater degree of transparency and liquidity."
About Vitalibis, Inc.
Vitalibis endeavours to be an iconic lifestyle brand, which promotes health and wellness within the rapidly growing medicinal cannabis industry. Vitalibis seeks to utilize a robust technology platform and innovative micro-influencer sales model to market and sell premium, full spectrum phyto-cannabinoid rich (PCR) hemp oil products, along with personal care and certified organic nutritional products formulated with premium hemp extracts. In addition to leveraging technology and selling high-quality products, Vitalibis will focus on supporting non-profits with environmental and neuro-emotional missions.
For additional information, www.vitalibis.com
Contact:
Vitalibis Inc.
702-944-9620
[email protected]
FORWARD LOOKING STATEMENT
This news release includes forward-looking statements that reflect Vitalibis Inc. current expectations about its future results, performance, prospects and opportunities Vitalibis, Inc. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties and other factors that could cause the Company's actual results, performance, prospects of opportunities for the remainder of 2018 and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.


Tokio Marine Eyes Multibillion-Dollar Suncorp Takeover
China EV Stocks Slide as Door Handle Recall Hits 4.3 Million Vehicles
Trump Buys SpaceX Shares After Record IPO
Ampol Profit Surges as Refining Margins Hit Record Highs
Luxshare Shares Rise as First-Half Profit Jumps 18%
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints
SK Hynix Shares Fall as Workers Reject Wage Deal
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Tesla Raises Cybertruck Prices by $5,000 in US
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone
Nvidia Eyes Perplexity Investment at $30 Billion Valuation
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7% 



